Evidence suggests that AQP-uEV concentration in patient urine can be used as a biomarker to determine AKI severity; Sonoda et al. have identified changes in AQP1 concentration in uEV in AKI rats with early AKI, without reduced urine osmolality or increased urine volume. The gene discussed is AQP1; the disease is acute kidney injury.